The Innovative Medicines Initiative (IMI), now the Innovative Health Initiative (IHI), funds promising projects across Europe to turn health research into real benefits for patients and society. However, many of these initiatives struggle to maintain impact once EU funding ends. Despite general recognition of the need for financial and organisational sustainability, there is a lack…
The success of multinational pediatric clinical trials depends on efficient, high-quality, and scalable trial support services. From 2018 to 2025, the conect4children (c4c) network – a public-private partnership funded by the Innovative Medicines Initiative 2 – brought together 10 pharmaceutical companies and 33 academic and third-sector organizations to develop such services across 220+ sites in…
